Spots Global Cancer Trial Database for wt1 analog peptide vaccine
Every month we try and update this database with for wt1 analog peptide vaccine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation | NCT01827137 | Multiple Myelom... Minimal Residua... High-Risk Cance... | WT1 Analog Pept... Sargramostim (G... lenalidomide | 18 Years - | Sellas Life Sciences Group |